Hepatitis C Information - Peregrine Pharmaceuticals Names Leading Influenza Expert to Its Scientific Resource Board

Peregrine Pharmaceuticals Names Leading Influenza Expert to Its Scientific Resource Board
PR Newswire - a Phase I clinical trial for the treatment of chronic hepatitis C infectionand is being studied preclinically for use in